BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 2798056)

  • 1. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Image analysis in patients with dementia].
    Tamaki N
    Hokkaido Igaku Zasshi; 1996 May; 71(3):303-7. PubMed ID: 8752524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of magnetic resonance imaging (MRI) and single photon emission computing tomography (SPECT) for the differential diagnosis of Parkinson's disease and other neurodegenerative disorders presenting as parkinsonism].
    Kohira I
    Nihon Rinsho; 1997 Jan; 55(1):39-42. PubMed ID: 9014421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.
    Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Mov Disord; 2005 Dec; 20(12):1571-6. PubMed ID: 16116613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and instrumental diagnosis of Alzheimer's and multi-infarct dementia].
    Fornarelli D; Ascoli G; Rossi R; Manca A; Lanza R; Moretti V; Scarpino O; Guidi M
    Radiol Med; 1996; 92(1-2):22-7. PubMed ID: 8966268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
    Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
    Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
    Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic differentiation of dementia diseases by modern imaging procedures].
    Lang C; Herholz K; Huk W; Feistel H
    Fortschr Neurol Psychiatr; 1990 Oct; 58(10):380-98. PubMed ID: 2272595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.
    Lyoo CH; Ryu YH; Lee MS
    Mov Disord; 2010 Mar; 25(4):496-9. PubMed ID: 20108369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroradiological study of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex on the Kii peninsula of Japan.
    Kokubo Y; Kuzuhara S
    Arch Neurol; 2003 Sep; 60(9):1257-61. PubMed ID: 12975292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.